Edition:
United Kingdom

Jubilant Life Sciences Ltd (JULS.NS)

JULS.NS on National Stock Exchange of India

987.95INR
10:25am GMT
Change (% chg)

Rs60.45 (+6.52%)
Prev Close
Rs927.50
Open
Rs942.70
Day's High
Rs997.80
Day's Low
Rs934.15
Volume
1,102,329
Avg. Vol
679,638
52-wk High
Rs1,039.00
52-wk Low
Rs600.00

Chart for

About

Jubilant Life Sciences Limited is an India-based pharmaceutical and life sciences company. The Company is engaged in providing basic organic chemicals. The Company's segments include Pharmaceuticals and Life Sciences Ingredients. The Pharmaceuticals segment consists of generics, including active pharmaceuticals ingredients... (more)

Overall

Beta: 1.54
Market Cap(Mil.): Rs105,929.90
Shares Outstanding(Mil.): 159.28
Dividend: 3.00
Yield (%): 0.45

Financials

  Industry Sector
P/E (TTM): -- 31.10 16.60
EPS (TTM): -- -- --
ROI: -- 14.90 10.66
ROE: -- 16.41 14.30

BRIEF-Jubilant Life Sciences Says Unit Got ANDA Approval For Amantadine Hydrochloride Tablets​

* UNIT, JUBILANT PHARMA GETS ANDA FINAL APPROVAL FOR AMANTADINE HYDROCHLORIDE TABLETS, GENERIC VERSION OF SYMMETREL OF ENDO​ Source text: http://bit.ly/2EtLooJ Further company coverage:

09 Feb 2018

BRIEF-Jubilant Life Sciences Says Unit Got ANDA Approval For Clonidine Hydrochloride Extended-Release Tablets‍​

* JUBILANT PHARMA GOT ANDA APPROVAL FOR CLONIDINE HYDROCHLORIDE EXTENDED-RELEASE TABLETS‍​ Source text: http://bit.ly/2Gt6DoZ Further company coverage:

30 Jan 2018

BRIEF-India's Jubilant Life Sciences Issues Commercial Papers Worth 900 Mln Rupees

* ISSUED COMMERCIAL PAPERS WORTH 900 MILLION RUPEES Source text - http://bit.ly/2mElAvi Further company coverage:

17 Jan 2018

BRIEF-India's Jubilant Life Sciences Dec Qtr Consol Profit Up 78 Pct

* DEC QUARTER CONSOL NET PROFIT 2.13 BILLION RUPEES VERSUS PROFIT OF 1.19 BILLION RUPEES LAST YEAR

17 Jan 2018

BRIEF-Jubilant Life Sciences Unit Gets sNDA Approval For New Indications From USFDA For Draximage DTPA

* SAYS UNIT GETS SNDA APPROVAL FOR NEW INDICATIONS FROM USFDA FOR DRAXIMAGE® DTPA Source text for Eikon: Further company coverage:

28 Dec 2017

BRIEF-Jubilant Life Sciences Says Co Not Got Formal Environmental Nod For Gujarat Pesticide Project

* CLARIFIES ON NEWS ITEM ON CO'S PESTICIDE PROJECT IN GUJARAT GETTING GREEN PANEL NOD

04 Dec 2017

BRIEF-Jubilant Life Sciences' unit to buy entire equity share capital of Jubilant Discovery Services ​

* Unit ‍drug Discovery and Development Solutions to buy entire equity share capital of Jubilant Discovery Services Inc​

22 Nov 2017

BRIEF-Jubilant Life Sciences issues commercial papers worth 500 mln rupees ‍​

Nov 3 Jubilant Life Sciences Ltd * Issued commercial papers worth 500 million rupees ‍​ Source text - http://bit.ly/2iZFtyJ Further company coverage:

03 Nov 2017

BRIEF-Jubilant Life Sciences issues commercial papers worth 500 mln rupees‍​

* Issues commercial papers worth 500 million rupees‍​ Source text: (http://bit.ly/2zui6kx) Further company coverage:

17 Oct 2017

Earnings vs. Estimates